Allosteric antipsychotics: m4 muscarinic potentiators as novel treatments for schizophrenia.
Division of Medicinal Chemistry, Department of Pharmacology, NIMH Psychoactive Drug Screening Program, University of North Carolina Chapel Hill Medical School, Chapel Hill, NC 27759, USA.
Martilias
M
Farrell
Bryan L
BL
Roth
D000494:Allosteric Regulation / Q000187:drug effects; D000818:Animals; D014150:Antipsychotic Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D002460:Cell Line; D006801:Humans; D051379:Mice; D051381:Rats; D043588:Receptor, Muscarinic M4 / Q000187:drug effects / Q000378:metabolism*; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents; D043588:Receptor, Muscarinic M4